Importantly, inhibiting USP7 not only sensitized tumor cells to T cell-mediated cytotoxicity by reducing cell surface PD-L1 levels and attenuating its interaction with PD-1, but it also decreased their proliferation by stabilizing p53 in vitro and in vivo. The gene discussed is PDCD1; the disease is neoplasm.